Indian Immunologicals
Indian Immunologicals Limited (IIL) is a leading biotechnology company committed to making healthcare affordable and accessible. The company specializes in research, product innovation, and manufacturing of vaccines, nutraceuticals, and formulations for both animal and human health. With a focus on quality, social responsibility, and sustainable development, IIL operates one of the largest plants in the world for veterinary vaccines and is a major player in the human vaccine market in India, especially in pediatric and rabies vaccines. The company also exports vaccines to over 50 countries and has a diverse portfolio of over 150 registered products. IIL's mission is to innovate, produce, and market quality healthcare products to improve and extend lives, guided by values of integrity, excellence, inclusiveness, and passion.
Industries
Nr. of Employees
Very Large (1000+)
Indian Immunologicals
Products
Livestock vaccine portfolio for major endemic diseases
A range of vaccines for livestock covering viral, bacterial and parasitic diseases used in preventive and mass immunization programs.
Companion-animal vaccine portfolio and multicomponent canine vaccines
Vaccines and multicomponent formulations for companion animals covering common viral and bacterial diseases, including combined freeze-dried and aqueous components where applicable.
Porcine cysticercosis recombinant vaccine (TSOL18 antigen)
Recombinant antigen vaccine produced using yeast expression and formulated with mineral/oil adjuvant for active immunization of pigs against porcine cysticercosis; includes defined dosing schedule and cold-chain storage requirements.
Veterinary therapeutic and nutraceutical formulations
Range of therapeutic formulations and feed/nutraceutical supplements including antibiotics, antiparasitics, NSAIDs, vitamins, minerals and specialty feed additives.
Livestock vaccine portfolio for major endemic diseases
A range of vaccines for livestock covering viral, bacterial and parasitic diseases used in preventive and mass immunization programs.
Companion-animal vaccine portfolio and multicomponent canine vaccines
Vaccines and multicomponent formulations for companion animals covering common viral and bacterial diseases, including combined freeze-dried and aqueous components where applicable.
Porcine cysticercosis recombinant vaccine (TSOL18 antigen)
Recombinant antigen vaccine produced using yeast expression and formulated with mineral/oil adjuvant for active immunization of pigs against porcine cysticercosis; includes defined dosing schedule and cold-chain storage requirements.
Veterinary therapeutic and nutraceutical formulations
Range of therapeutic formulations and feed/nutraceutical supplements including antibiotics, antiparasitics, NSAIDs, vitamins, minerals and specialty feed additives.
Services
On-site third-party production of vaccines, biologicals and veterinary formulations compliant with certified quality systems for domestic and export markets.
Supply and operational coordination of large-scale vaccination programs for government and institutional customers, including logistics and post-vaccination monitoring.
Export and distribution services for veterinary and human biologicals with established cold-chain logistics to support international delivery.
Centralized adverse event monitoring and reporting services via an online portal and regulatory reporting workflows.
Workshops, publications and online resources to support veterinarians with disease guidance, vaccination protocols and field implementation.
On-site third-party production of vaccines, biologicals and veterinary formulations compliant with certified quality systems for domestic and export markets.
Supply and operational coordination of large-scale vaccination programs for government and institutional customers, including logistics and post-vaccination monitoring.
Export and distribution services for veterinary and human biologicals with established cold-chain logistics to support international delivery.
Centralized adverse event monitoring and reporting services via an online portal and regulatory reporting workflows.
Workshops, publications and online resources to support veterinarians with disease guidance, vaccination protocols and field implementation.
Expertise Areas
- Veterinary vaccine R&D and manufacturing
- Recombinant antigen vaccine development
- Vaccine formulation and adjuvant systems
- GMP biologics and vaccine contract manufacturing
Key Technologies
- BSL-3 containment and workflows
- Yeast (Pichia pastoris) recombinant protein expression
- Oil-adjuvanted vaccine formulation
- Lyophilization (freeze-drying) and reconstitution